- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Negative Type; Schizophrenic in New Zealand
Total 10715 results
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
Forest LaboratoriesCompletedSchizophreniaUnited States
-
Northwell HealthActive, not recruitingSchizophrenia | Bipolar DisorderUnited States
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the ExtremitiesNew Zealand, Germany, Belgium, Australia, Austria
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Medtronic - MITGCompletedHIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial LesionsUnited States
-
Medco Health Solutions, Inc.SureGene, LLCCompletedSchizophrenia | Bipolar DisorderUnited States
-
Roswell Park Cancer InstituteNational Center for Advancing Translational Sciences (NCATS)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; BayerActive, not recruitingEsophagogastric Cancer | HER2-NegativeUnited States
-
PfizerCompletedSmoking CessationUnited States, Canada
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
National Institute on Drug Abuse (NIDA)CompletedTobacco Use Disorder | Schizophrenia and Disorders With Psychotic FeaturesUnited States
-
Yale UniversityNational Alliance for Research on Schizophrenia and DepressionCompleted
-
Nathan Kline Institute for Psychiatric ResearchJazz PharmaceuticalsCompletedSchizophrenia | Insomnia Related to Schizophrenia (307.42)United States
-
Rovi Pharmaceuticals LaboratoriesCompleted
-
University of Illinois at ChicagoWeill Medical College of Cornell University; Janssen, LPCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
National Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Massachusetts General HospitalAstraZeneca; OncoPep, Inc.Active, not recruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer Center3M; Miami Cancer InstituteCompletedNegative-Pressure Wound TherapyUnited States
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
Northwell HealthNational Institute of Mental Health (NIMH)CompletedSchizophrenia | First Episode PsychosisUnited States
-
NYU Langone HealthNational Institutes of Health (NIH)CompletedSchizophrenia | Psychosis | Schizo Affective Disorder | SchizophreniformUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)Enrolling by invitationSchizophrenia | Schizoaffective DisorderUnited States
-
Merck Sharp & Dohme LLCCompleted
-
New York State Psychiatric InstituteNathan Kline Institute for Psychiatric ResearchCompleted
-
Mclean HospitalYale University; University of LausanneNot yet recruitingCognitive Impairment | Schizophrenia and Related Disorders | Mitochondrial AlterationUnited States, Switzerland
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
CephalonCompletedSchizophreniaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Recruiting
-
GlaxoSmithKlineCompleted
-
Yale UniversityStanley Medical Research InstituteCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Hoffmann-La RocheCompleted
-
Cerevel Therapeutics, LLCCompletedSchizophreniaUnited States
-
Novartis PharmaceuticalsCompletedSchizophreniaUnited States
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
Forest LaboratoriesCompletedEvaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsSchizophreniaUnited States
-
Proteus Digital Health, Inc.Massachusetts General Hospital; The Zucker Hillside HospitalCompletedSchizophrenia | Bipolar DisorderUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Columbia UniversityCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Intellia TherapeuticsActive, not recruitingTransthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac AmyloidosisFrance, United Kingdom, New Zealand, Sweden
-
Nathan Kline Institute for Psychiatric ResearchCompletedSchizophrenia | Cognition | Cigarette SmokingUnited States
-
University of PittsburghPatient-Centered Outcomes Research Institute; Dartmouth CollegeCompletedSchizophrenia | Bipolar Disorder | Major DepressionUnited States
-
Northwell HealthBoston University; University of Pittsburgh; Dartmouth-Hitchcock Medical CenterCompletedSchizophrenia | Schizoaffective Disorder | Psychosis NOSUnited States
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
PfizerCompleted
-
Columbia UniversityRecruitingTriple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States